Myalept Injection, Powder, Lyophilized, For Solution
Product Images NDC 10122-210

Product Visual Gallery

This gallery contains 82 technical images submitted to the FDA as part of the official labeling for Myalept (NDC 10122-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Myalept 1)

An instructional illustration depicting components for preparing Myalept injection. It shows a vial labeled 'Water for Injection' with a cap and liquid inside, alongside a syringe assembled with a plunger, a longer needle attached to the syringe tip, and a needle cover removed and placed nearby. The diagram labels each part to guide mixing the lyophilized powder for subcutaneous injection.*

FDA Label Image

Wash Hands (Myalept 10)

An instructional illustration showing handwashing: a person washing hands under a running faucet with soap, with water flowing into the sink. The image suggests proper hygiene preparation, likely related to safe medication handling or injection preparation.*

FDA Label Image

Alcohol Swabs (Myalept 11)

An instructional illustration depicting two opened packets, one labeled 'Diluent' and the other labeled 'Myalept powder.' The image appears to show the preparation of Myalept (metreleptin) injection, powder, lyophilized, for subcutaneous administration.*

FDA Label Image

Remove Vial Caps (Myalept 12)

An instructional illustration showing a vial labeled 'Water for Injection' being prepared by a hand removing a flip-off cap, indicating steps for reconstituting a lyophilized powder for injection.*

FDA Label Image

Clean Bottles With Alcohol (Myalept 13)

An instructional illustration shows a person removing the cap from a vial labeled 'Water for Injection' and holding another smaller vial positioned next to it, suggesting preparation for mixing or reconstitution of medication.*

FDA Label Image

Mixing Syringe (Myalept 14)

Myalept 11.3 mg/2.2 mL injection vial represented as a pre-filled syringe for subcutaneous use. The syringe has clear volume markings from 0.5 to 2 mL and a purple cap at the needle end, indicating it is intended for precise dosing. Product is from Chiesi USA, Inc.*

FDA Label Image

Water For Injection (Myalept 15)

A clear glass vial with a silver metal cap and a white label printed with "Water for Injection". The vial appears to contain a clear liquid. No other visible branding or strength information is shown on the label in this image.*

FDA Label Image

Image (Myalept 16)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution in a single vial with a red cap and label. The vial is intended for subcutaneous use and is manufactured by Chiesi USA, Inc. The packaging displays typical vial features including a flip-off cap and clear body showing the powder inside.*

FDA Label Image

Step 2a (Myalept 17)

Myalept 11.3 mg/2.2 mL lyophilized powder for subcutaneous injection vial with label showing the proprietary name, active ingredient metreleptin, and labeler Chiesi USA, Inc. The vial label includes dosage form information and NDC 10122-210.*

FDA Label Image

Pull Cover (Myalept 18)

An instructional illustration showing a person holding a syringe and removing a cap from its tip, indicated by a red arrow pointing to the cap being pulled away.*

FDA Label Image

Pull Down Plunger (Myalept 19)

Illustration showing a step in preparing a subcutaneous injection, specifically drawing liquid from a vial into a syringe with a downward arrow indicating the direction of movement. This visual aids in the administration process for Myalept (metreleptin) injection, powder, lyophilized, for solution.*

FDA Label Image

Figure A (Myalept 2)

An instructional diagram showing components for subcutaneous injection of Myalept (metreleptin) powder for solution, including a vial with powder and cap, insulin and tuberculin syringes with plungers, needles, and covers, alcohol wipes, a sharps disposal container, stickers to note discard date, and a pen for writing on the stickers.*

FDA Label Image

Line Up With Black Rim (Myalept 20)

An instructional illustration showing a close-up of a syringe being filled to a 2.2 mL mark. The image highlights the 2.2 mL level on the syringe measurement scale, with a red arrow pointing to it, indicating the correct volume for dose preparation.*

FDA Label Image

Set Vial On Surface (Myalept 21)

An instructional illustration showing a hand holding a syringe and drawing solution from a vial labeled "Myalept metreleptin injection". The image depicts the preparation for subcutaneous injection of Myalept powder reconstituted for administration.*

FDA Label Image

Push Needle (Myalept 22)

An instructional illustration showing a person holding a syringe above a vial labeled with "Myalept". A downward red arrow indicates the motion of drawing medication from the vial into the syringe, demonstrating the preparation step for subcutaneous injection of Myalept (metreleptin) injection, powder, lyophilized, for solution.*

FDA Label Image

Turn Vial (Myalept 23)

An instructional illustration showing a pair of hands drawing solution from a vial labeled with a syringe. The vial is held upside down and a plunger on the syringe is pulled to withdraw the medication. A green-circled label '2e' marks the step in the process. The image likely depicts preparation of a subcutaneous injection solution.*

FDA Label Image

Pull Plunger (Myalept 24)

An instructional illustration demonstrating the preparation of an injection with a syringe and a vial. It shows a hand holding the syringe and vial with an arrow indicating downward motion. A magnified inset focuses on the syringe measurement markings between 2 and 3 mL.*

FDA Label Image

Check For Air Pockets (Myalept 25)

An instructional diagram showing a syringe filled with solution and labeled "Air pocket." A hand is visible holding the syringe, and the volume markings on the syringe are shown, including a 1 mL mark. The diagram highlights the presence of a 2g air pocket in the syringe.*

FDA Label Image

Push Plunger (Myalept 26)

An instructional illustration showing a hand drawing liquid from a vial into a syringe with an upward arrow indicating the direction for pulling the plunger. The image demonstrates preparation of an injection dose, likely related to Myalept (metreleptin) for subcutaneous administration.*

FDA Label Image

Check For Airbubbles (Myalept 27)

An instructional diagram depicting a syringe with measurement markings in milliliters. Labels highlight an air bubble near the 2 mL mark, with a marker indicating a 2-hour time period. The image focuses on proper syringe handling or air bubble management for injection preparation.*

FDA Label Image

Push Plunger (Myalept 28)

An instructional illustration showing a hand holding a syringe attached to a vial, with the syringe plunger being pulled upward, indicated by a red arrow. This depicts the step of drawing medication into the syringe, relevant for subcutaneous injection preparation.*

FDA Label Image

Pull Plunger (Myalept 29)

An instructional illustration showing a hand holding a vial labeled with a measurement scale. The vial is connected to a syringe, with a zoomed-in circle emphasizing the measurement markings on the vial. The image appears to demonstrate how to measure and draw up medication from the vial.*

FDA Label Image

Figure B (Myalept 3)

An instructional illustration showing how to measure 2.2 mL of liquid in a syringe. It explains that each short line equals 0.1 mL, marks the 2.0 mL and 2.2 mL lines, and advises lining up the top rim of the plunger (not the dome) with the 2.2 mL line for accurate measurement.*

FDA Label Image

Remove From Vial (Myalept 30)

An instructional illustration showing a hand holding a vial upside down and using a syringe to withdraw liquid from the vial. It is part of a step-by-step guide, indicated by the number 2 in the top left corner, relating to preparation or administration of an injectable medication.*

FDA Label Image

Filled Syringe (Myalept 31)

A detailed illustration of a medical syringe filled with liquid, including measurement markings on the barrel and a needle attached at the tip. The plunger is visible at the bottom, designed for subcutaneous injection.*

FDA Label Image

Powder Vial (Myalept 32)

The image shows a clear glass vial with a gray rubber stopper and an aluminum seal. It likely contains a lyophilized powder medication, corresponding to Myalept (metreleptin) injection, powder, lyophilized, for solution, subcutaneous use. The vial is unlabelled in the image and appears unused.*

FDA Label Image

Sharps Disposal Container (Myalept 33)

Myalept 11.3 mg/2.2 mL lyophilized powder for solution injection vial, subcutaneous use, with red-orange cap and clear glass body. Label indicates product by Chiesi USA, Inc.*

FDA Label Image

Set The Vial (Myalept 34)

An instructional illustration showing two hands preparing a subcutaneous injection. One hand holds a vial and the other holds a syringe, with a red arrow indicating the direction to draw the medication from the vial into the syringe. The image is likely related to the administration of Myalept (metreleptin) injection.*

FDA Label Image

Tilt The Vial (Myalept 35)

An illustration showing a pair of hands preparing an injection. One hand is holding a syringe, drawing liquid medication from a vial held by the other hand, demonstrating the process of filling a syringe for subcutaneous injection.*

FDA Label Image

Push Plunger (Myalept 36)

An instructional diagram showing two hands preparing a subcutaneous injection by drawing solution from a vial into a syringe using a needle. The image demonstrates proper technique for reconstituting or administering an injectable medication.*

FDA Label Image

Add The Liquid (Myalept 37)

An illustration depicting a vial containing a powder for solution, likely the lyophilized injection form of Myalept (metreleptin). A needle is shown inserted into the vial's rubber stopper, indicating preparation for subcutaneous injection.*

FDA Label Image

Remove The Needle (Myalept 38)

An instructional illustration showing two steps of preparing a subcutaneous injection. The first part depicts drawing solution from a vial using a syringe. The second part shows inserting the needle through a rubber stopper into a vial or container, suggesting preparation for injection.*

FDA Label Image

Mix Powder And Liquid (Myalept 39)

An instructional illustration showing a hand holding a vial of Myalept (metreleptin) injection, powder, lyophilized, for solution, turning the vial cap in a clockwise direction. The image is part of preparation or administration instructions for subcutaneous use.*

FDA Label Image

Figure C (Myalept 4)

An instructional diagram demonstrating how to measure doses using syringes. It includes a labeled example of a tuberculin syringe showing short, medium, and long measurement lines and their volume equivalents, alongside two insulin syringes with corresponding measurement notations. Insets highlight the plunger position for a 0.05 mL dose, instructing to line the top rim of the plunger with the unit line for accurate dosing.*

FDA Label Image

Mixed Vial (Myalept 40)

An illustration of a glass vial with a gray stopper containing a liquid solution. The vial is shown upright with a reflective surface underneath.*

FDA Label Image

Mixed Vial (Myalept 41)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized for solution, in a small clear vial with a purple and white label. The label shows the proprietary name Myalept and indicates it is a lyophilized powder for subcutaneous injection. Manufactured or labeled by Chiesi USA, Inc.*

FDA Label Image

Alcohol Wipes (Myalept 42)

Myalept (metreleptin) injection powder, lyophilized, for solution, supplied as alcohol wipes in individual sachets. Each sachet is labeled 'Alcohol Wipe' in red text on a predominantly white background. The product is by Chiesi USA, Inc.*

FDA Label Image

Take Mixed Vial (Myalept 43)

The image shows a single clear vial labeled as Myalept 11.3 mg/2.2 mL lyophilized powder for injection. The vial has a gray cap and a label indicating it is a closed vial to be used after reconstitution. The labeler is Chiesi USA, Inc.*

FDA Label Image

Set Vial On Surface (Myalept 44)

An instructional diagram showing a vial of Myalept (metreleptin) 11.3 mg/2.2 mL lyophilized powder for injection. The image includes an icon indicating to wait for 10-15 minutes, likely representing a preparation or reconstitution time step before subcutaneous administration.*

FDA Label Image

Wash Hands (Myalept 45)

Illustration showing hands being washed under running water with soap being applied, indicated by a soap dispenser and lather. The image emphasizes hand hygiene, likely related to preparation or administration guidance for Myalept (metreleptin) injection.*

FDA Label Image

Remove Wipes (Myalept 46)

An instructional diagram showing two medication packets labeled with the Myalept brand. The image indicates a 3-hour time interval, likely illustrating timing or preparation steps for the injection powder, lyophilized form of metreleptin for subcutaneous use.*

FDA Label Image

Clean Vial Top (Myalept 47)

An instructional illustration showing two hands preparing a vial of Myalept injection powder for solution. One hand holds the vial labeled with the product name and dosage, while the other hand is removing or placing the vial cap, indicating preparation for subcutaneous administration.*

FDA Label Image

Check Mixed Medicine (Myalept 48)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution vial for subcutaneous use. The vial label displays the brand name Myalept and includes pertinent product identification details. The labeler is Chiesi USA, Inc.*

FDA Label Image

Figure (Myalept 49)

Illustration showing three different syringe types and their volume capacities: a 1 mL tuberculin syringe, a 1 mL insulin syringe, and a 0.3 mL insulin syringe, each labeled accordingly to indicate the syringe size and type.*

FDA Label Image

Image (Myalept 5)

Text excerpt from a dosage instruction section of a drug label, showing fields for specifying the dose to be taken each day and the date, with measurement units in milliliters (mL). The content appears to be part of patient directions or dosing information for a prescription drug.*

FDA Label Image

Figure (Myalept 50)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution, in a clear glass vial with a silver cap. The vial is labeled for subcutaneous use and is manufactured by Chiesi USA, Inc.*

FDA Label Image

Figure (Myalept 51)

An illustration depicting a vial with a sealed, crimped cap and a rubber stopper, typically used for pharmaceutical injections. The vial is shown in a reddish color with a white seal area on the top. This image is likely related to the packaging or preparation of injectable drugs.*

FDA Label Image

Step 4a (Myalept 52)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution, subcutaneous use. The label shows the proprietary name Myalept and generic name metreleptin. Manufactured by Chiesi USA, Inc., the packaging includes dosage form and strength information along with usage instructions and NDC 10122-210.*

FDA Label Image

Figure (Myalept 53)

An instructional illustration showing hands preparing a syringe by attaching or securing a needle to the syringe barrel. This image appears related to the preparation or administration process for Myalept (metreleptin) injection, powder, lyophilized, for solution, but does not include specific text or product labeling.*

FDA Label Image

Figure (Myalept 54)

Illustration showing the process of connecting a syringe to a vial adapter, with an arrow indicating the direction to attach the syringe to the vial for preparation of an injection.*

FDA Label Image

Figure (Myalept 55)

An instructional illustration showing a hand holding a syringe with the thumb pushing the plunger downward, accompanied by a red arrow indicating the direction to depress the plunger. This diagram is likely part of usage or administration directions for an injectable drug.*

FDA Label Image

Figure (Myalept 56)

An instructional illustration showing a hand holding a syringe positioned to withdraw medication from a vial held by another hand, labeled with a step number '4d'. This demonstrates part of the preparation process for administering the Myalept (metreleptin) lyophilized powder injection.*

FDA Label Image

Figure (Myalept 57)

An instructional illustration showing a hand holding a syringe with a needle inserted into a vial, illustrating the process of drawing medication from the vial for injection.*

FDA Label Image

Figure (Myalept 58)

An instructional illustration showing a hand holding a syringe with an injection vial inverted above it, depicting the process of drawing medication from the vial into the syringe. This image relates to subcutaneous injection preparation for the drug Myalept (metreleptin) lyophilized powder for solution.*

FDA Label Image

Figure (Myalept 59)

An instructional illustration showing a person's hand holding a vial and drawing liquid into a syringe. A red downward arrow indicates the direction of drawing the medication from the vial into the syringe. This image is likely part of a procedure for preparing a subcutaneous injection of Myalept (metreleptin) lyophilized powder for solution.*

FDA Label Image

Check For Expiration Date (Myalept 6)

Myalept 11.3 mg/2.2 mL injection, lyophilized powder for solution. The vial label displays the brand name Myalept, the generic name metreleptin, strength, and instructions to reconstitute before use. The label also shows the manufacturer's name, Chiesi USA, Inc., and includes space for the lot number and expiration date.*

FDA Label Image

Figure (Myalept 60)

An instructional illustration showing a syringe with a visible air pocket inside the liquid. The air pocket is labeled clearly, demonstrating proper recognition or handling during preparation of a subcutaneous injection. The image highlights the liquid level and air space within the syringe, relevant for preparing Myalept (metreleptin) injection.*

FDA Label Image

Figure (Myalept 61)

Instructional illustration showing a hand holding a syringe that is drawing liquid from a vial. An upward red arrow indicates the motion of pulling the plunger to withdraw the solution, demonstrating how to prepare an injection for subcutaneous administration.*

FDA Label Image

Figure (Myalept 62)

An illustration showing a syringe with a visible air bubble inside the liquid. The diagram highlights the air bubble and notes a 4-hour time period, likely indicating a waiting or observation interval post-injection preparation.*

FDA Label Image

Figure (Myalept 63)

An illustration showing a hand drawing liquid from a vial into a syringe. The vial is inverted above the syringe, and an upward red arrow indicates the direction of pulling the liquid into the syringe, demonstrating the preparation step for a subcutaneous injection.*

FDA Label Image

Figure (Myalept 64)

Illustration showing a step in the preparation of an injection, depicting a hand holding a vial and drawing solution into a syringe, indicated by a red downward arrow. The image is part of an instructional sequence labeled with '4i'.*

FDA Label Image

Figure (Myalept 65)

An instructional illustration showing a hand holding a vial and another hand drawing liquid from it into a syringe. The vial is upside down and appears to contain a lyophilized powder to be reconstituted for subcutaneous injection. The image is likely part of preparation steps for Myalept 11.3 mg/2.2 mL injection by Chiesi USA, Inc.*

FDA Label Image

Figure (Myalept 66)

An illustration of a syringe with a needle attached. The syringe barrel is graduated with measurement markings for precise dosing. The plunger is partially depressed, showing readiness for injection. The needle is covered with an orange safety cap.*

FDA Label Image

Figure (Myalept 67)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution. The image shows the vial label and packaging for this subcutaneous prescription drug containing metreleptin. The labeler is Chiesi USA, Inc. Packaging includes product and dosage information, branding, and regulatory details.*

FDA Label Image

Figure (Myalept 68)

Myalept 11.3 mg/2.2 mL injection, powder, lyophilized, for solution, presented in a vial with a red label and a white cap. The product is labeled by Chiesi USA, Inc. The vial is designed for subcutaneous administration.*

FDA Label Image

Figure (Myalept 69)

An instructional illustration showing recommended injection sites for Myalept (metreleptin) subcutaneous injection. It depicts front and back views of a human body with labeled areas including the back of the upper arm, stomach, and upper thigh as suitable locations for injection.*

FDA Label Image

Water For Injection (Myalept 7)

A clear vial labeled Water for Injection with a pink cap. The vial is filled with a clear solution. There is no indication of dosage strength, manufacturer, or other product information visible on the label.*

FDA Label Image

Figure (Myalept 70)

An instructional illustration showing a hand pressing a small adhesive patch or gauze square onto the skin, demonstrating how to apply pressure or secure it after a subcutaneous injection.*

FDA Label Image

Figure (Myalept 71)

Instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of the opposite arm. The image highlights the proper technique for injection, relevant to the subcutaneous route of administration.*

FDA Label Image

Figure (Myalept 72)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the forearm, indicated by a red arrow pointing downwards. The image is likely related to the administration of Myalept (metreleptin) injection.*

FDA Label Image

Figure (Myalept 73)

Instructional illustration showing a hand holding a syringe vertically above a vial, demonstrating the step of withdrawing medication. The syringe needle is inside the vial's rubber stopper. The icon '5d' appears in the upper left corner, suggesting it is part of a multi-step process.*

FDA Label Image

Figure (Myalept 74)

Myalept 11.3 mg/2.2 mL vial, a lyophilized powder injection for subcutaneous use. The label includes storage instructions to store only if mixed with bacteriostatic water for injection. Manufactured by Chiesi USA, Inc.*

FDA Label Image

Figure (Myalept 75)

An illustration of a calendar page showing the month of January with dates clearly numbered. The 1st and 9th are circled in red ink, indicating specific marked days. The calendar layout includes the days of the week abbreviated at the top.*

FDA Label Image

Figure (Myalept 76)

Label segment for Myalept (metreleptin) injection, powder, lyophilized, for solution, 11.3 mg/2.2 mL by Chiesi USA, Inc. This portion shows a boxed area with the instruction to discard the vial after the date entered, with a blank space labeled "January 1" for date entry.*

FDA Label Image

Figure (Myalept 77)

An illustration showing a hand holding a vial of medication labeled Myalept with another hand holding a syringe, demonstrating the preparation for subcutaneous injection of Myalept injection, powder, lyophilized, for solution by Chiesi USA, Inc.*

FDA Label Image

Figure (Myalept 78)

A sheet of medication vial discard labels featuring the phrase 'Discard vial after dose on:' printed repeatedly with blank lines for date or other notations. The labels are arranged in two columns with a purple and red border, intended for use with injectable medications like Myalept (metreleptin) 11.3 mg/2.2 mL lyophilized powder for solution, subcutaneous injection by Chiesi USA, Inc.*

FDA Label Image

Medicine Vials (Myalept 79)

The image shows two clear glass vials with gray caps. The vial on the right has a white label with blue and red text, displaying the brand name Myalept. The vials are for metreleptin injection, powder, lyophilized, intended for subcutaneous use. The packaging suggests a sterile drug product suitable for reconstitution prior to administration.*

FDA Label Image

Myalept Powder (Myalept 8)

A clear glass vial with a silver/gray cap and a white label that wraps around the vial. The vial is designed for injecting a lyophilized powder intended for solution preparation. No visible text or branding is present on the label in the image.*

FDA Label Image

Check Forair Bubbles (Myalept 80)

An instructional illustration comparing syringe plungers showing differences in air bubble sizes. A red X marks a syringe with large air bubbles, while a green check mark highlights a syringe with small air bubbles, indicating correct technique for subcutaneous injection preparation.*

FDA Label Image

Bottle Label (Myalept 81)

Myalept (metreleptin) 11.3 mg per vial injection label for subcutaneous use. The label includes storage instructions (refrigerate at 36°F to 46°F), directions for single or multi-dose vial preparation, NDC 10122-210-01, and manufacturer information for Chiesi Farmaceutici S.p.A., Parma, Italy, licensed for use by Chiesi USA, Inc.*

FDA Label Image

Carton Label (Myalept 82)

Packaging label for Myalept (metreleptin) Injection, 11.3 mg per vial, by Chiesi USA, Inc. The label states the drug is a lyophilized powder for subcutaneous injection, with storage instructions and contents after reconstitution. The label also includes directions to use the vial with water or bacteriostatic water for injection, cautions about child safety, and the product NDC 10122-210-02.*

FDA Label Image

Alcohol Wipes (Myalept 9)

Myalept 11.3 mg/2.2mL injection powder, lyophilized, for subcutaneous use, is shown alongside two individually packaged alcohol wipe sachets. The alcohol wipes are labeled simply as "Alcohol Wipe." Labeler is Chiesi USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.